Burden and consequences of influenza, SARS-CoV-2 and other respiratory viruses among Indian adults

Who could benefit from this research

What this research studies

Researchers at the All India Institute of Medical Sciences, New Delhi, will expand to multiple sites to study adults 18–60 who experience severe respiratory infections from influenza, SARS-CoV-2, and other viruses. They will measure how often these infections occur, the costs of treatment, and the short- and long-term health effects, including risk of reinfection. The project will also assess vaccine hesitancy and uptake among healthcare workers and evaluate vaccine effectiveness against severe illness. A national SARI platform (INSPIRES) will link hospitals, establish a SARI registry, and build capacity among health professionals to inform policy and prevention strategies.

Why it matters

Where this research is happening

• All-India Institute of Medical Sciences
  New Delhi, India Active

Researchers

• Principal investigator: Krishnan, Anand — All-India Institute of Medical Sciences
• Study coordinator: Krishnan, Anand

Related research

Other NIH-funded projects on the same topics.

• Understanding flu and COVID-19 vaccine responses in people and in the lab

  Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.

  NIH research Stanford University · Stanford, United States · NIH-11591264

• Leptin and fat cells: how obesity may worsen lung infections like COVID-19 and flu

  A study explores how fat tissue and the leptin pathway might change the body's first lung defenses during respiratory infections in people who are obese or have diabetes.

  NIH research Louisiana State Univ A&m Col Baton Rouge · Baton Rouge, United States · NIH-11382855

• Vaccine effectiveness in preventing respiratory illness in Washington state (2022–2027)

  This project tests how well vaccines against flu, COVID-19, and other respiratory viruses protect people in Washington state from getting acutely ill.

  NIH research Kaiser Foundation Health Plan of Washington · Seattle, United States · NIH-11379693

• Understanding flu and COVID-19 vaccine responses in adults

  A Stanford-led effort studies how the flu and COVID-19 vaccines work in adults and how to make them work better for people, especially those with higher risk from underlying health conditions.

  NIH research Stanford University · Stanford, United States · NIH-11333210

• How flu, COVID-19, and other respiratory vaccines protect people in Washington from sudden respiratory illness

  This project checks how well seasonal flu, COVID-19, and other respiratory vaccines prevent short-term respiratory illnesses in people living in Washington state.

  NIH research Kaiser Foundation Health Plan of Washington · Seattle, United States · NIH-11170380

• Tracking serious influenza, COVID-19, and other respiratory infections in working-age Indian adults

  This project follows adults aged 18–60 in India who get severe respiratory infections to find out how often they happen, what long-term problems and costs result, and how well vaccines protect against serious illness.

  NIH research All-India Institute of Medical Sciences · New Delhi, India · NIH-11137548

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.